LiverMultiScan Biomarker Helps Autoimmune Hepatitis Patients Manage Illnesses
The MRI-derived non-invasive tissue biomarker improved autoimmune hepatitis (AIH) management by identifying patients in biochemical remission
Read MorePosted by Andy Lundin | Mar 30, 2022 | Infectious Diseases |
The MRI-derived non-invasive tissue biomarker improved autoimmune hepatitis (AIH) management by identifying patients in biochemical remission
Read MorePosted by Andy Lundin | Mar 30, 2022 | Microscopy |
Researchers has developed a technology that could replace conventional biopsies and histology with real-time imaging within the living body.
Read MorePosted by Andy Lundin | Mar 30, 2022 | Sepsis |
A new test can predict sepsis before blood clots cause organ damage by detecting shifts in blood protein abundance soon after infection.
Read MorePosted by Andy Lundin | Mar 29, 2022 | Covid 19, Flu & Respiratory Infections, Immunoassay Reagents & test Kits |
Visby Medical received $25.5 million in federal funding to develop and validate an at-home combination Flu-Covid test from BARDA.
Read MorePosted by Chris Wolski | Mar 25, 2022 | POC Instruments, Stroke |
Thanks to male fertility testing research, a new POC test has been developed that will allow rapid diagnosis of stroke or concussion.
Read More